| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.004 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |